How Lateral Flow Assays Work | Early Cancer Diagnostics Guide
How Lateral Flow Assays Work: A Guide to Rapid Diagnostic Technology in Early Cancer Diagnostics How Lateral Flow Assays Work Lateral flow assays (LFAs) are among the most widely used…
Stay informed with the latest news, company updates, research highlights, industry perspectives, and strategic developments from OncoFirm™ Diagnostics. Our Newsroom shares stories about cancer diagnostic innovation, biomarker research, AI-assisted technologies, collaborations, intellectual property, and the evolving future of rapid and accessible cancer detection.
“By detecting cancer at its earliest, most treatable stage, OncoFirm empowers healthcare workers and systems to save more lives — efficiently and affordably.”
OncoFirm Scientific Publications
© 2025 OncoFirm Diagnostics Corporation. All Rights Reserved.
How Lateral Flow Assays Work: A Guide to Rapid Diagnostic Technology in Early Cancer Diagnostics How Lateral Flow Assays Work Lateral flow assays (LFAs) are among the most widely used…
Why Early Cancer Detection Matters: The Foundation of Modern Cancer Diagnostics Why Early Detection Matters Early cancer detection is one of the most significant factors influencing patient care, treatment planning,…
AI-Driven Biomarkers: The Future of Precision Diagnostics Unlocking the Invisible Signals of Health In a world where early detection saves lives, AI-driven biomarkers are revolutionizing how we understand, monitor, and…
Head of Investor Relations OncoFirm™ Diagnostics | Location: Flexible (East Coast preferred) | Reports to: CEO About OncoFirm™ OncoFirm™ Diagnostics is redefining early cancer detection through proprietary, emotionally intelligent diagnostic…
Researchers applied MIGHT to liquid biopsy data, focusing on ccfDNA fragmentation patterns (e.g., fragment lengths, positions, and end motifs) to determine which features reliably indicate cancer: Challenge: False Positives Linked…
1. Explosive Global Growth 2. Clinical Need Meets Technological Promise 3. Regional Drivers and Adoption Summary Table Metric Value 2024 Global Market Size USD 1.0 – 1.24 billion 2030 Forecast…
Peanut agglutinin (PNA) plays a role in cancer detection because it specifically binds to the Thomsen–Friedenreich antigen (T-antigen) — a carbohydrate structure that is hidden in normal cells but exposed…
When it’s exposed, it can be detected by specific antibodies (like peanut agglutinin), and its presence is linked to disease processes. The Thomsen–Friedenreich antigen (T antigen) — sometimes called the…
Biochemical diagnostics is the branch of laboratory medicine that uses chemical and biochemical tests to detect, measure, and interpret changes in the body’s biochemical processes for the purpose of diagnosing…
Alpha-fetoprotein (AFP) is a protein normally produced by the fetal liver and yolk sac during development. In adults, AFP levels are usually very low, so an elevated AFP can be…